Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Intermediate Risk Management. MARK Study

NCT01428934 is registered in ClinicalTrials.gov with Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina as lead sponsor.

NCT NCT01428934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Intermediate Risk Management. MARK Study
Lead sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Phase
Observational
Overall status
Completed
Start date
July 31, 2011
Completion date
December 31, 2016
Enrollment
2,495 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina pectoris, myocardial infarction, peripheral arterial disease, stroke